Apogee Therapeutics Inc (APGE)
SG&A Expense Growth
12.98%
Quarterly · Period ending:
APGE SG&A Expense Growth
Latest reported12.98%period ending
Latest reported12.98%period ending
APGE Quarterly SG&A Growth (QoQ) (0.00% → 12.98%)
Latest values, visible window
High-resolution chart · PNG
APGE sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 12.9821% | |
| 7.2958% | |
| 17.4269% | |
| -0.2159% | |
| 3.4468% | |
| 5.8395% | |
| 20.6599% | |
| 18.8347% | |
| 15.3302% | |
| 15.4128% | |
| 13.3361% | |
| 46.5074% | |
| 17.5113% | |
| 122.2634% | |
| 204.0193% | |
| 69.0217% | |
| 513.3333% | |
| 0% |